You are here

Vertex Pharmaceuticals

Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis

Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis

CP Wire

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis

Vertex Pharmaceuticals

Flag link:

CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test

CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test

Xconomy

CRISPR Therapeutics

Vertex Pharmaceuticals

sickle cell disease

Flag link:

3 Biotech Stocks With Virtual Monopolies

3 Biotech Stocks With Virtual Monopolies

Motley Fool

Alexion Pharmaceuticals

Vertex Pharmaceuticals

Flag link:

Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination

Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination

CP Wire

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week

Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week

Motley Fool

CRISPR Therapeutics

Vertex Pharmaceuticals

Flag link:

First CRISPR clinical trial backed by U.S. companies launches

First CRISPR clinical trial backed by U.S. companies launches

Stat

clinical trials

beta thalassemia

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Vertex taps Genomics for target discovery help, makes investment

Vertex taps Genomics for target discovery help, makes investment

Fierce Biotech

Vertex Pharmaceuticals

machine learning

Flag link:

Vertex cystic fibrosis drug gets expanded approval for use in infants

Vertex cystic fibrosis drug gets expanded approval for use in infants

Reuters

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly

Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly

Endpoints

Vertex Pharmaceuticals

cystic fibrosis

tezacaftor/ivacaftor

Flag link:

The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs

The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs

Yahoo/Benzinga

Pain Therapeutics

Vertex Pharmaceuticals

lumacaftor/ivacaftor

Flag link:

First rumors about Gilead – Vertex or Gilead – Pfizer merger start circulating

First rumors about Gilead – Vertex or Gilead – Pfizer merger start circulating

GoinPharma

Gilead Sciences

Vertex Pharmaceuticals

Flag link:

Vertex and Alexion Are Schooling Big Biotech

Vertex and Alexion Are Schooling Big Biotech

Washington Post, DC

Vertex Pharmaceuticals

Flag link:

Vertex spars with UK's May over Orkambi pricing

Vertex spars with UK's May over Orkambi pricing

Biopharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Galapagos shares are tumbling following disappointing results from a cystic fibrosis trial.

Galapagos shares are tumbling following disappointing results from a cystic fibrosis trial.

Motley Fool

cystic fibrosis

Vertex Pharmaceuticals

Flag link:

5 Experimental New Drugs That Could Be Worth $47 Billion

5 Experimental New Drugs That Could Be Worth $47 Billion

Motley Fool

VX-659 + tezacaftor + ivacaftor

Vertex Pharmaceuticals

Flag link:

Vertex doubles size of cystic fibrosis drug discovery site

Vertex doubles size of cystic fibrosis drug discovery site

Fierce Biotech

Vertex Pharmaceuticals

drug development

cystic fibrosis

Flag link:

Big Biotech Set for Earnings Blowout?

Big Biotech Set for Earnings Blowout?

Barron's

Gilead Sciences

Vertex Pharmaceuticals

Flag link:

FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

Xconomy

sickle cell disease

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Pages